ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

ProPhase Labs Inc.

These are the upcoming stock splits for the week of December 22 to December 26, based on TipRanks’ Stock Splits Calendar. A stock split is generall...

Upcoming Stock Splits This Week (December 22 to December 26) – Stay Invested

Prophase Labs ( ($PRPH) ) just unveiled an update. ProPhase Labs, Inc. announced that it has entered into a non-binding letter of intent for a prop...

ProPhase Labs Announces Proposed Reverse Merger with ABL

Earnings, analyst updates, economic data, and more make up the top stock market stories for Friday.


Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!

Prophase Labs ( ($PRPH) ) has shared an announcement. On November 24, 2025, ProPhase Labs, Inc. conducted a Special Meeting of Stockholders where s...

Prophase Labs Approves Strategic Proposals at Special Meeting

Prophase Labs ( ($PRPH) ) has shared an announcement. On November 21, 2025, ProPhase Labs, Inc. received confirmation from Avtech Capital, LLC to c...

Prophase Labs Secures Forbearance Agreement with Avtech Capital

Prophase Labs ( ($PRPH) ) has provided an update. On November 21, 2025, ProPhase Labs, Inc. disclosed that a civil action filed against it in 2023 ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRPH	$0.69	-29.18%	2.67M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PRPH	$0.69	-29.2%	2.67M
3
4
5
6

PRPH

PRPH

Get ProPhase Labs Inc. Data in Excel

Get ProPhase Labs Inc. Data in Excel